Clinical Trials Directory

Trials / Completed

CompletedNCT03516890

Management of Spontaneous Ruptured Hepatocellular Carcinoma

Management of Spontaneous Ruptured Hepatocellular Carcinoma - Partial Hepatectomy and Prognosis: A Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
216 (actual)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
15 Years – 76 Years
Healthy volunteers
Not accepted

Summary

To investigate the best treatment for hepatocellular carcinoma rupture

Detailed description

To investigate the best treatment for hepatocellular carcinoma rupture, transcatheter arterial embolization or partial hepatectomy. Furthermore, to discuss the choice of emergency or staged hepatectomy.

Conditions

Interventions

TypeNameDescription
PROCEDUREPartial hepatectomyPartial hepatectomy was comprised of single or multiple liver resections aiming to excise all macroscopic tumors.

Timeline

Start date
2005-01-01
Primary completion
2015-06-01
Completion
2017-12-01
First posted
2018-05-04
Last updated
2018-05-04

Source: ClinicalTrials.gov record NCT03516890. Inclusion in this directory is not an endorsement.

Management of Spontaneous Ruptured Hepatocellular Carcinoma (NCT03516890) · Clinical Trials Directory